-
2061
-
2062
-
2063
-
2064
-
2065
-
2066
Genomic profiles of Indonesian colorectal cancer patients [version 2; peer review: 2 approved]
Published 2023-02-01Get full text
Article -
2067
-
2068
COVID-19 Inmate Risk Appraisal (CIRA): development and validation of a screening tool to assess COVID-19 vulnerability in prisons
Published 2021-02-01“…Underlying data will be updated regularly on the website (http://www.prison-research.com), where the CIRA algorithm is freely available. …”
Get full text
Article -
2069
-
2070
-
2071
-
2072
-
2073
-
2074
-
2075
-
2076
-
2077
-
2078
Disutilities Associated with Intravenous Iron Infusions: Results from a Time Trade-off Survey and Diminishing Marginal Utility Model for Treatment Attributes in China
Published 2023-09-01“…Shanlian Hu,1 Depei Wu,2 Jing Wu,3 Yabing Zhang,4 Mette Bøgelund,5 Johannes Pöhlmann,6 Richard F Pollock6 1School of Public Health, Fudan University, Shanghai, People’s Republic of China; 2First Affiliated Hospital of Soochow University, Soochow University, Suzhou, People’s Republic of China; 3School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, People’s Republic of China; 4Shanghai Institute of Technology, Shanghai, People’s Republic of China; 5Incentive Partners ApS, Holte, Denmark; 6Covalence Research Ltd, Harpenden, United KingdomCorrespondence: Richard F Pollock, Covalence Research Ltd, Rivers Lodge, West Common, Harpenden, AL5 2JD, United Kingdom, Tel +44 20 8638 6525, Email pollock@covalence-research.comPurpose: Treatment process attributes can affect health state utilities associated with therapy. …”
Get full text
Article -
2079
-
2080